Neuroendocrine tumors. Peptide receptor radionuclide therapy.
about
Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumoursInternational Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease statesGastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsNeuroendocrine tumors of the gastro-entero-pancreatic systemSomatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.Gastric neuroendocrine tumours.Bombesin receptor-mediated imaging and cytotoxicity: review and current statusPositron emission tomography imaging of cancer biology: current status and future prospectsNANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasCan DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?Applications of molecular imaging.Cancer stratification by molecular imaging.A multimodal approach to the management of neuroendocrine tumour liver metastasesInsulinoma: pathophysiology, localization and managementEstimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphyPriorities for improving the management of gastroenteropancreatic neuroendocrine tumors.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesPET and SPECT Imaging of Tumor Biology: New Approaches towards Oncology Drug Discovery and Development.Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrSomatostatin analog octreotide LAR in gastro-entero-pancreatic tumors.Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.Gastrointestinal neuroendocrine tumors.Non-functioning pancreatic neuroendocrine tumors--a case report and review of literature.Liver-specific therapies for metastases of neuroendocrine pancreatic tumorsFuture perspectives on neuroendocrine tumors.Radiometallated peptides for molecular imaging and targeted therapy.Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors.Contemporary management of nonfunctioning pancreatic neuroendocrine tumors.Emerging therapeutic options for advanced enteropancreatic neuroendocrine tumors.Radionuclide therapy beyond radioiodine.Non-functional pancreatic neuroendocrine tumor as an incidentaloma--a case report and review of literature.Current molecular imaging positron emitting radiotracers in oncology.Relevance of radiobiological concepts in radionuclide therapy of cancer.Quantitative SPECT/CT Imaging of (177)Lu with In Vivo Validation in Patients Undergoing Peptide Receptor Radionuclide Therapy.Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation.Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method.[Lu]-DOTA-Tyr-octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma.Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting.Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors.A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.
P2860
Q24241069-74E47880-17F3-4579-8C0C-F297D9579418Q24643524-19952CBC-EA63-4EED-80B4-70F03CAA6FE5Q28290833-51658A9E-1943-499C-B8AC-37E6C0A89418Q28294432-3D547946-5D72-4050-918F-64DB52002C12Q33753449-528DBFB9-5262-4A08-B5C8-6674085DB82CQ34306680-D4C8FFFC-D91D-4FFB-86D5-CCEBC0484FC7Q34684387-FA31698C-E7AE-482C-AE59-D6A649465113Q34697688-19954E57-876D-4B3E-B434-4D76C74A0FFCQ35001777-8A85DA50-39AA-4110-8DE5-0C5C82D050F8Q35015049-C46979AC-F74F-46C5-BBB9-A01E40B17D11Q35082412-7A48B95A-2CC0-4031-91F6-09006A03A13EQ35380664-E84A39A4-F6E2-49B9-A17C-C6E9926A8CB6Q35810562-449C6CE8-5654-4A25-A84E-978C0553758CQ36400951-F8D71293-527A-4368-9EC5-AB61DAC56E0EQ36423806-DEE41026-3AED-4AAC-B9E3-08CD1075DA53Q36882123-C9E93C0E-8F93-4AA5-9E6A-A8E1EDB50C1EQ37125550-3FD2F3D4-0595-4654-BF2F-5C382594B862Q37374442-5EE0CB2F-D5F0-4845-8CAE-D217B029BE37Q37425156-0BB0A44C-B2F3-4CDC-8860-5C2A215F98ECQ37483944-BD823495-8B00-4E93-A3C4-FC0446B2DA84Q37564373-10F82904-CB28-4ACF-A87A-B7E3413E1356Q37799954-A38640B1-8B84-4680-8DB4-DAD2D291C0D7Q37802274-53BDBBA3-BEA5-47DE-B58A-1E6A7DA5ECA0Q37821300-F0F1C7B5-20B3-482C-8C14-4A69B3A22070Q37843819-7D98D46C-D754-4D9A-AFE4-0A13BC0D5C13Q37847064-AD47F03B-D3D9-46DF-B4D8-4AC48DFB9A80Q37936908-EFC8CF49-F18B-4A4F-8A4D-14A3FEA446A3Q37947138-00F56855-9221-4811-A7A4-7AA781CA015CQ37980202-78B420D8-5114-423B-8BFB-147272CDD1F8Q38027798-5976618B-DF0B-4DDB-8922-A3915E4DD10AQ38052101-EF7498ED-795C-4A63-AD83-56D9B9914684Q38217835-AA3DC9BD-F8F9-4882-BA3E-D57DE774134CQ38751028-F1330088-BBA3-4B36-B359-20CC01CF6CD1Q39084045-B74DE457-6B4F-45B4-B7D6-0F635844832CQ39289085-F7690982-080C-4D1A-A7DF-6F8773DCDED7Q39590527-4CD01354-CE0F-4736-A612-22A9E8B3E31FQ39606627-241F4A44-60E3-4B47-B40B-FE1DFF85DF9FQ39973557-314B4C42-6557-443F-A801-8A1AA15DEA30Q41244010-03D00EEA-37BA-44E0-B12C-489FFA75723DQ41485304-E016DBA3-4BFD-4B41-A73F-7E1C02A7E11B
P2860
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
@ast
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
@en
type
label
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
@ast
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
@en
prefLabel
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
@ast
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
@en
P2093
P1476
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
@en
P2093
Dik J Kwekkeboom
Eric P Krenning
Flavio Forrer
Marion de Jong
Roelf Valkema
P304
P356
10.1016/J.BEEM.2007.01.007
P577
2007-03-01T00:00:00Z